Join host Amy Board as we continue to dive into the evolving world of bleeding disorder treatments. This episode of Ask the Expert explores how emerging therapies—like rebalancing and non-factor agents—are tested, monitored, and kept safe.

With insights from Drs. Mark Redding, Janice Stabler, and Tammy Singleton, we break down the complexities of dosing, breakthrough bleeds, and surgical planning, showing why safety checks and open communication with your care team are more critical than ever. Learn how these therapies fine-tune the clotting system without replacing missing factors and why staying informed is key to confident, safe care.

Ask the Expert is produced by Believe Limited, and is found only on the BloodStream Media Podcast Network.

Presented by Sanofi

#MyHemophiliaTruth. Real stories. Powered by Sanofi. It's time to consider the whole experience when it comes to managing hemophilia and change the conversation. Explore the full story at www.myhemophiliatruth.com

The Bigger Picture in Hemophilia B:

Hemophilia A and hemophilia B are different bleeding disorders with unique pathologies and clinical features.1 Due to the distinct behavior of factor IX, multiple PK parameters should be considered when assessing bleed prevention. Learn how a broader view of PK may influence evaluation of treatment and management for patients with hemophilia B.2,3 Learn more at thebiggerpictureinhemb.com

Did you know BloodStreamMedia.com is your one-stop shop for all podcasts for the bleeding disorders and rare disease community?

→ BloodStreamMedia.com

→ BloodStream Media on Facebook

→ BloodStream Media on Instagram

→ BloodStream Media on LinkedIn